IBL Tool - Digital Library

Digital Library

Journal description

All volumes of the corresponding journal

All issues of the corresponding volume

All articles of the corresponding issues

87 results found

no	title	author	magazine	year	volume	issue	page(s)	type
1	Absence of altered in vivo concentration of dorsolateral prefrontal cortex GABA in recent onset schizophrenia	Yoon, Jong H.			243	C	p. 383-384	article
2	Accessibility of psychiatric vocabulary: An international study about schizophrenia essential features	Askevis-Leherpeux, Françoise			243	C	p. 463-464	article
3	Adaptive and maladaptive consequences of increased social media and internet use during the COVID-19 pandemic in schizophrenia	Zhang, Luyu			243	C	p. 472-474	article
4	Adherence to recommended health and social distancing precautions during the COVID-19 pandemic in individuals with schizophrenia and youth at clinical high-risk for psychosis	Macdonald, Kelsey I.			243	C	p. 446-448	article
5	Aerobic exercise and cognitive functioning in schizophrenia: Findings of dose-response analysis from a pilot randomized controlled trial	Shimada, Takeshi			243	C	p. 443-445	article
6	Altered corollary discharge in the auditory cortex could reflect louder inner voice experience in patients with verbal hallucinations, a pilot fMRI study	Stephane, Massoud			243	C	p. 475-480	article
7	A meta-analysis of social cognitive deficits in schizophrenia: Does world region matter?	Weinreb, Susannah			243	C	p. 206-213	article
8	Amitriptyline for clozapine-induced hypersalivation: A case series	Cereda, Guido			243	C	p. 110-111	article
9	AMPA receptors in schizophrenia: A systematic review of postmortem studies on receptor subunit expression and binding	Yonezawa, Kengo			243	C	p. 98-109	article
10	An opportunity for primary prevention research in psychotic disorders	Gershon, Elliot S.			243	C	p. 433-439	article
11	An overall protective effect of antipsychotic drugs against COVID-19 seems implausible	Ruiz de Pellón-Santamaría, Ángel			243	C	p. 486-488	article
12	Anti-aggressive effects of clozapine in involuntarily committed black patients with severe mental illness	Cavaliere, Vincent S.			243	C	p. 163-169	article
13	Antipsychotics and Attenuated Psychosis Syndrome: Transdiagnostic assessment and discontinuation strategies	Fusar-Poli, Paolo			243	C	p. 402-404	article
14	A potential objective marker in first-episode schizophrenia based on abnormal niacin response	Hu, YeGang			243	C	p. 405-412	article
15	A proxy measure of premorbid adjustment in psychosis for large-scale epidemiological studies and electronic health record-based research	López-Díaz, Álvaro			243	C	p. 467-469	article
16	A redux of schizophrenia research in 2021	Suhas, Satish			243	C	p. 458-461	article
17	Assessment of treatment resistance criteria in non-invasive brain stimulation studies of schizophrenia	Kronick, Jami			243	C	p. 349-360	article
18	Association between incarceration and psychotic experiences in a general population sample	Narita, Zui			243	C	p. 112-117	article
19	Association of g-quadruplex variants with schizophrenia symptoms	Bhattacharyya, Upasana			243	C	p. 361-363	article
20	Attaching importance to the risk of all-cause, sudden death, and cardiovascular mortality among antipsychotic-treated patients with schizophrenia	Tang, Chao-Hsiun			243	C	p. 462	article
21	(Attenuated) hallucinations join basic symptoms in a transdiagnostic network cluster analysis	Jimeno, Natalia			243	C	p. 43-54	article
22	Can peripheral brain-derived neurotrophic factor (BDNF) be a potential biomarker of suicide risk in schizophrenia?	Mamtani, Harkishan			243	C	p. 203-205	article
23	Childhood trauma is associated with poorer social functioning in severe mental disorders both during an active illness phase and in remission	Hjelseng, Ingrid Varvin			243	C	p. 241-246	article
24	Clinical and treatment predictors of relapse during a three-year follow-up of a cohort of first episodes of schizophrenia	Bioque, Miquel			243	C	p. 32-42	article
25	Clinical high risk for psychosis in children and adolescents: A meta-analysis of transition prevalences	Raballo, Andrea			243	C	p. 254-261	article
26	Computerised cognitive training during early-stage psychosis improves cognitive deficits and gamma-band oscillations: A pilot study	Haining, Kate			243	C	p. 217-219	article
27	Core clinical manifestations of clozapine-related DRESS syndrome: A network analysis	de Filippis, Renato			243	C	p. 451-453	article
28	COVID-19 contamination and severity among patients with schizophrenia: Results from a specialized outpatient clinic survey	Costardi, Carlos Gustavo			243	C	p. 465-466	article
29	Disparities in technology literacy and access negatively impact cognitive remediation scalability	Arlia, Christina			243	C	p. 456-457	article
30	Editorial Board				243	C	p. IFC	article
31	Effects of country of origin and wave of immigration on prevalence of schizophrenia among first and second-generation immigrants: A 30-year retrospective study	Eger, G.			243	C	p. 247-253	article
32	Effects of paranoia on well-being in adolescents: A longitudinal mediational analysis	Kingston, J.L.			243	C	p. 178-180	article
33	Ex vivo 1H-MRS brain metabolic profiling in a two-hit model of neurodevelopmental disorders: Prenatal immune activation and peripubertal stress	Capellán, Roberto			243	C	p. 232-240	article
34	Fatigue in psychosis	Poole-Wright, K.			243	C	p. 392-394	article
35	Further evidence and meta-analysis support association of a single nucleotide polymorphism rs4765905 in CACNA1C with schizophrenia	Wang, Zuxing			243	C	p. 454-455	article
36	Gender differences in the association between environment and psychosis	Pence, Aysegul Yay			243	C	p. 120-137	article
37	Gender-specific elevation of plasma anthranilic acid in schizophrenia: Protection against glutamatergic hypofunction?	Steiner, Johann			243	C	p. 483-485	article
38	Has improved treatment contributed to the declining rate of transition to psychosis in ultra-high-risk cohorts?	Formica, M.J.C.			243	C	p. 276-284	article
39	Identifying strategies to improve PANSS based dimensional models in schizophrenia: Accounting for multilevel structure, Bayesian model and clinical staging	Higuchi, Cinthia H.			243	C	p. 424-430	article
40	Internalized stigma among people with schizophrenia: Relationship with socio-demographic, clinical and medication-related features	Barlati, Stefano			243	C	p. 364-371	article
41	In this issue				243	C	p. A1	article
42	Investigation of accelerated epigenetic aging in individuals experiencing suicidal ideation	Dada, Oluwagbenga			243	C	p. 307-309	article
43	Investigation of accelerated epigenetic aging in individuals suffering from schizophrenia in the context of lifetime suicide attempt	Jeremian, Richie			243	C	p. 222-224	article
44	It's never too late to admit it's too early!	Malhi, Gin S.			243	C	p. 296-297	article
45	Letter to the editor: The critical eye of science should know no borders	Chang, Bernard P.			243	C	p. 413	article
46	Longitudinal symptom changes and association with home time in people with schizophrenia: An observational digital phenotyping study	Ranjan, Tanvi			243	C	p. 64-69	article
47	Means of suicide in psychiatric patients: Population-based data from Israel between 2001 and 2020	Bergman-Levy, Tal			243	C	p. 118-119	article
48	Metamotivation in people diagnosed with schizophrenia: A conceptual introduction and qualitative study	Hansen, Marie C.			243	C	p. 317-321	article
49	Multimorbidity landscape of schizophrenia: Insights from meta-analysis of genome wide association studies	Gawde, Ulka			243	C	p. 214-216	article
50	Negative schizotypy attenuates the effect of momentary stress on social dysfunction related to COVID-19 social distancing	Masucci, Michael D.			243	C	p. 24-31	article
51	Network signatures of rTMS treatment in patients with schizophrenia and auditory verbal hallucination during an auditory-motor task using HD-EEG	Banea, Ovidiu C.			243	C	p. 310-314	article
52	Neural correlates of disturbance in the sense of agency in schizophrenia: An fMRI study using the ‘enfacement’ paradigm	Salgado-Pineda, Pilar			243	C	p. 395-401	article
53	Neurocognitive and social cognitive training for youth at clinical high risk (CHR) for psychosis: A randomized controlled feasibility trial	Friedman-Yakoobian, Michelle S.			243	C	p. 302-306	article
54	Neurodegenerative model of schizophrenia: Growing evidence to support a revisit	Stone, William S.			243	C	p. 154-162	article
55	Neurometabolic patterns of an “at risk for mental disorders” syndrome involve abnormalities in the thalamus and anterior midcingulate cortex	Smesny, Stefan			243	C	p. 285-295	article
56	New variants and new symptoms in COVID-19: First episode psychosis and Cotard's Syndrome two months after infection with the B.1.1.7 variant of coronavirus	Yesilkaya, Umit Haluk			243	C	p. 315-316	article
57	North American Prodrome Longitudinal Study (NAPLS 3): Methods and baseline description	Addington, Jean			243	C	p. 262-267	article
58	Plasma lipid alterations in young adults with psychotic experiences: A study from the Avon Longitudinal Study of Parents and Children cohort	Yin, Xiaofei			243	C	p. 78-85	article
59	Population density is unrelated to prevalence of psychotic experience across 4 U.S. cities	Marsh, Jonathan			243	C	p. 449-450	article
60	Pragmatic implementation of the Clinical Global Impression Scale of Severity as a tool for measurement-based care in a first-episode psychosis program	Khau, Michelle			243	C	p. 147-153	article
61	Prisoner's dilemma game in recovered schizophrenia patients, compared with healthy controls: Preliminary findings	Igata, Ryohei			243	C	p. 431-432	article
62	Real-time facial emotion recognition deficits across the psychosis spectrum: A B-SNIP Study	Rubin, Leah H.			243	C	p. 489-499	article
63	Recent health-related stressful life events predictive of emergent suicidal ideation in schizophrenia	Tasmim, Samia			243	C	p. 220-221	article
64	Reducing public stigma toward individuals with psychosis across race and gender: A randomized controlled trial of young adults	Amsalem, Doron			243	C	p. 195-202	article
65	Relationship between plasma clozapine/N-desmethylclozapine and changes in basal forebrain-dorsolateral prefrontal cortex coupling in treatment-resistant schizophrenia	Sarpal, Deepak K.			243	C	p. 170-177	article
66	Reply to Evans et al.: Towards informed choice in cannabis use	Holt, Daphne J.			243	C	p. 481-482	article
67	Schizophrenia: A developmental disorder with a risk of non-specific but avoidable decline	Murray, R.M.			243	C	p. 181-186	article
68	Sex and gender associations with indicators of neurodevelopmental compromise in schizophrenia spectrum disorders	Luckhoff, Hilmar Klaus			243	C	p. 70-77	article
69	Sex differences in antipsychotic-related triglyceride levels are associated with metabolic hormone differences in patients with severe mental disorders	Johansen, Ingrid Torp			243	C	p. 55-63	article
70	Shortening telomere is associated with psychotic dimensions in the general population	Schürhoff, Franck			243	C	p. 470-471	article
71	Spared performance but increased uncertainty in schizophrenia: Evidence from a probabilistic decision-making task	Kreis, Isabel			243	C	p. 414-423	article
72	Starting clozapine in patients with schizophrenia during the ongoing pandemic	Grover, Sandeep			243	C	p. 440-442	article
73	Striatal functional connectivity in psychosis relapse: A hypothesis generating study	Rubio, Jose M.			243	C	p. 342-348	article
74	Structural and diffusion MRI based schizophrenia classification using 2D pretrained and 3D naive Convolutional Neural Networks	Hu, Mengjiao			243	C	p. 330-341	article
75	Thalamic and striato-pallidal volumes in schizophrenia patients and individuals at risk for psychosis: A multi-atlas segmentation study	Takahashi, Tsutomu			243	C	p. 268-275	article
76	The Disease Recovery Evaluation and Modification (DREaM) study: Effectiveness of paliperidone palmitate versus oral antipsychotics in patients with recent-onset schizophrenia or schizophreniform disorder	Alphs, Larry			243	C	p. 86-97	article
77	The effect on relapse rate and psychiatric symptomatology: Switching a combination of first- and second-generation antipsychotic polypharmacy to antipsychotic monotherapy in long-term inpatients with schizophrenia and related disorders. A pragmatic randomized open-label trial (SwAP trial)	Shakir, Mushde			243	C	p. 187-194	article
78	The effects of voice content on stress reactivity: A simulation paradigm of auditory verbal hallucinations	Baumeister, David			243	C	p. 225-231	article
79	The potential role of self-criticism in distress related to attenuated psychotic symptoms and implications for clinical trajectory	Hickey, Tara			243	C	p. 298-299	article
80	The role of insecure attachment and psychological mechanisms in paranoid and depressive symptoms: An exploratory model	Trucharte, Almudena			243	C	p. 9-16	article
81	The trajectories and correlates of two negative symptom subdomains in first-episode schizophrenia	Phahladira, Lebogang			243	C	p. 17-23	article
82	The viability of the frequency following response characteristics for use as biomarkers of cognitive therapeutics in schizophrenia	Clayson, Peter E.			243	C	p. 372-382	article
83	The 10-year trajectories of auditory hallucinations among 496 patients with a first schizophrenia-spectrum disorder: Findings from the OPUS cohort	Köhler-Forsberg, Ole			243	C	p. 385-391	article
84	Three major psychiatric disorders share specific dynamic alterations of intrinsic brain activity	Zhang, Luheng			243	C	p. 322-329	article
85	Unpacking the phenomenon of declining transition rates to first episode psychosis: The dyad of science and service reform in action	Daneault, Jean-Gabriel			243	C	p. 300-301	article
86	We both say tomato: Intact lexical alignment in schizophrenia and bipolar disorder	Sharpe, Victoria			243	C	p. 138-146	article
87	What is obsession? Differentiating obsessive-compulsive disorder and the schizophrenia spectrum	Rasmussen, Andreas Rosén			243	C	p. 1-8	article

87 results found

Koninklijke Bibliotheek - National Library of the Netherlands